These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38333526)

  • 21. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis.
    Sobanski V; Giovannelli J; Allanore Y; Riemekasten G; Airò P; Vettori S; Cozzi F; Distler O; Matucci-Cerinic M; Denton C; Launay D; Hachulla E;
    Arthritis Rheumatol; 2019 Sep; 71(9):1553-1570. PubMed ID: 30969034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.
    Cavazzana I; Vojinovic T; Airo' P; Fredi M; Ceribelli A; Pedretti E; Lazzaroni MG; Garrafa E; Franceschini F
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):412-430. PubMed ID: 35716254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis.
    Iniesta Arandia N; Simeón-Aznar CP; Guillén Del Castillo A; Colunga Argüelles D; Rubio-Rivas M; Trapiella Martínez L; García Hernández FJ; Sáez Comet L; Egurbide Arberas MV; Ortego-Centeno N; Freire M; Marí Alfonso B; Vargas Hitos JA; Ríos Blanco JJ; Todolí Parra JA; Rodríguez-Carballeira M; Marín Ballvé A; Chamorro Fernández AJ; Pla Salas X; Madroñero Vuelta AB; Ruiz Muñoz M; Fonollosa Pla V; Espinosa G;
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):98-105. PubMed ID: 28980912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Presentation and Long-Term Outcomes of Systemic Sclerosis Portuguese Patients from a Single Centre Cohort: A EUSTAR Registration Initiative.
    Vidal C; Ruano C; Bernardino V; Lavado Carreira P; Lladó A; Santos MC; Gruner H; Panarra A; Riso N; Moraes-Fontes MF
    Acta Med Port; 2018 Jun; 31(6):312-320. PubMed ID: 30020876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marker antibodies in scleroderma and polymyositis: clinical associations.
    de Rooij DJ; Van de Putte LB; Habets WJ; Van Venrooij WJ
    Clin Rheumatol; 1989 Jun; 8(2):231-7. PubMed ID: 2547546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bosentan For Digital Ulcers in Patients With Systemic Sclerosis: Single Center Experience.
    Küçükşahin O; Yildizgören MT; Gerede DM; Maraş Y; Erten Ş
    Arch Rheumatol; 2016 Sep; 31(3):229-233. PubMed ID: 29900941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies versus Skin Fibrosis Extent in Systemic Sclerosis: A Case-Control Study of Inverted Phenotypes.
    Tieu A; Chaigne B; Dunogué B; Dion J; Régent A; Casadevall M; Cohen P; Legendre P; Terrier B; Costedoat-Chalumeau N; Le Jeunne C; Mouthon L
    Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
    Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
    Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppression use in early systemic sclerosis may be increasing over time.
    Park R; Nevskaya T; Baron M; Pope JE
    J Scleroderma Relat Disord; 2022 Feb; 7(1):33-41. PubMed ID: 35386940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS).
    Bellando-Randone S; Del Galdo F; Lepri G; Minier T; Huscher D; Furst DE; Allanore Y; Distler O; Czirják L; Bruni C; Guiducci S; Avouac J; Cutolo M; Smith V; Matucci-Cerinic M;
    Lancet Rheumatol; 2021 Dec; 3(12):e834-e843. PubMed ID: 38287630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Characteristics and Outcome of Primary Sjogren's Syndrome: A Large Asian Indian Cohort.
    Sandhya P; Jeyaseelan L; Scofield RH; Danda D
    Open Rheumatol J; 2015; 9():36-45. PubMed ID: 26161156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
    Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
    Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features and outcome of 1054 patients with Systemic Sclerosis: analysis of Reuma.pt/SSc registry.
    Freitas R; Martins P; Dourado E; Santiago T; Guimarães F; Fernandes BM; Garcia S; Samões B; Pinto AS; Gonçalves N; Lourenço MH; Costa E; Rocha M; Couto M; Duarte AC; Araújo F; Cordeiro I; Godinho F; Resende C; Salvador MJ; Cordeiro A; Santos MJ
    ARP Rheumatol; 2022; 1(1):21-29. PubMed ID: 35633574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.
    Zanatta E; Huscher D; Ortolan A; Avouac J; Airò P; Balbir-Gurman A; Siegert E; Matucci Cerinic M; Cozzi F; Riemekasten G; Hoffmann-Vold AM; Distler O; Gabrielli A; Heitmann S; Hunzelmann N; Montecucco C; Morovic-Vergles J; Ribi C; Doria A; Allanore Y;
    Rheumatology (Oxford); 2022 Nov; 61(12):4786-4796. PubMed ID: 35348643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis?
    Diot E; Giraudeau B; Diot P; Degenne D; Ritz L; Guilmot JL; Lemarié E
    Chest; 1999 Sep; 116(3):715-20. PubMed ID: 10492277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics associated with small airways disease in systemic sclerosis.
    Varma S; Yun JH; Kim JS; Podolanczuk AJ; Patel NM; Bernstein EJ
    J Scleroderma Relat Disord; 2022 Jun; 7(2):128-134. PubMed ID: 35585957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry.
    Riccieri V; Pellegrino G; Cipolletta E; Giuggioli D; Bajocchi G; Bellando-Randone S; Dagna L; Zanframundo G; Foti R; Cacciapaglia F; Cuomo G; Ariani A; Rosato E; Lepri G; Girelli F; Zanatta E; Bosello SL; Cavazzana I; Ingegnoli F; De Santis M; Murdaca G; Abignano G; Romeo N; Della Rossa A; Caminiti M; Iuliano A; Ciano G; Beretta L; Bagnato G; Lubrano E; De Andres I; Giollo A; Saracco M; Agnes C; Lumetti F; Spinella A; Magnani L; Campochiaro C; De Luca G; Codullo V; Visalli E; Di Vico C; Gigante A; Saccon F; Grazia Lazzaroni M; Franceschini F; Generali E; Mennillo G; Barsotti S; Pagano Mariano G; Calabrese F; Furini F; Vultaggio L; Parisi S; Peroni CL; Bianchi G; Conti F; Cozzi F; D'Angelo S; Doria A; Fusaro E; Govoni M; Guiducci S; Iannone F; Salvarani C; Sebastiani GD; Ferri C; Matucci-Cerinic M; De Angelis R
    J Scleroderma Relat Disord; 2024 Feb; 9(1):38-49. PubMed ID: 38333531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database.
    Morgan ND; Shah AA; Mayes MD; Domsic RT; Medsger TA; Steen VD; Varga J; Carns M; Ramos PS; Silver RM; Schiopu E; Khanna D; Hsu V; Gordon JK; Gladue H; Saketkoo LA; Criswell LA; Derk CT; Trojanowski MA; Shanmugam VK; Chung L; Valenzuela A; Jan R; Goldberg A; Remmers EF; Kastner DL; Wigley FM; Gourh P; Boin F
    Medicine (Baltimore); 2017 Dec; 96(51):e8980. PubMed ID: 29390428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.